NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Car-T is infusing the body with a tumor killing army. DCVax-L is educating, but not infusing the body with a huge army of cells to kill tumors quickly. There may be reasons to be able to do the two together that will create more dramatic results and also that might impact many more patients, and also inoperable patients at later stages. There may be different cancers where this will be very useful.

If you can do it all with the same blood draws and if you have a library of tumors that generate a library of neoantigens to use, it’s a whole new, customized immunotherapy power house company that can do it all, more efficiently and on a more personalized basis.